GUARDANT HEALTH INC. news, videos and press releases
For more news please use our advanced search feature.
GUARDANT HEALTH INC. - More news...
GUARDANT HEALTH INC. - More news...
- New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer
- Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
- Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference
- Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test
- Guardant Health to Participate in Upcoming August Investor Conferences
- Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
- Guardant Health Reports Second Quarter 2020 Financial Results
- Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant
- Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020
- Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic
- Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development
- Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal Cancer
- Guardant Health Appoints Vijaya Gadde to its Board of Directors
- Guardant Health Announces Full Exercise of Option and Closing of Public Offering
- Guardant Health Announces Pricing of Upsized Public Offering
- Guardant Health Announces Proposed Public Offering of Common Stock
- Guardant Health to Participate in the William Blair 2020 Growth Stock Conference
- Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer
- Guardant Health Reports First Quarter 2020 Financial Results
- Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference
- Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for Patients with Metastatic Non-Small Cell Lung Cancer
- Guardant Health Presents Data at DDW Virtual Meeting Highlighting its Early Cancer Detection Program
- Guardant Health Announces Webcast of First Quarter Financial Results on May 7, 2020
- Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer
- Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook
- Guardant Health to Participate in Upcoming Investor Conferences
- Guardant Health to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020
- Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information Officer
- Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C Inhibitor
- Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Circulating Tumor DNA Guided Adjuvant Therapy in Stage II Colon Cancer
